Biogen Idec Issues Statement on U.S. Approval of AMPYRAa

Full story: Earth Times

Biogen Idec today issued the following statement regarding the United States Food and Drug Administration approval of AMPYRA to improve walking in patients with multiple sclerosis .

Read

Comments below

Add to my Tracker

More Biogen Idec Discussions »

Email me Biogen Idec news. Learn more

Comments

Showing posts 1 - 1 of1

SLPPERY WHEN WET

Bronx, NY

GREAT GET IT APPROVED ALREADY WHY WAIT

Tell me when this thread is updated:
(Registration is not required)

Add to my Tracker

Send me an email

Showing posts 1 - 1 of1

Type in your comments below

Name
(appears on your post)

Comments

Characters left: 4000

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Biogen Idec Discussions

Search the Biogen Idec Forum:

Topic	Updated	Last By	Comments
Drug for relapsing forms of MS, Tecfidera appro...	May 15	Kasey	5
Biogen sets $55K annual price tag on new MS drug	Apr '13	Chris	1
FDA approves new multiple sclerosis capsules	Mar '13	Anonymous	2
Biogen Idec to offset tax for gay staff	Dec '12	snyper	6
Multiple Sclerosis drug maker Biogen shuttering... (Nov '10)	Nov '10	gumby	1
Amorfix Receives Third Biogen Idec Investment (Dec '08)	Jun '10	Rob	5
Whatever Tysabri Outcome, Biogen Idec Should Su... (Nov '09)	Nov '09	Sarah	1